Document Detail

First Canadian experience with high-risk percutaneous coronary intervention with assistance of a percutaneously deployed left ventricular assist device.
MedLine Citation:
PMID:  18987766     Owner:  NLM     Status:  MEDLINE    
Mechanical assist devices play an increasing role in high-risk percutaneous coronary intervention (PCI) in highly complex and critically ill patients. The Impella Recover LP 2.5 is a minimally invasive left ventricular assist device that is inserted percutaneously via a 13 Fr sheath. The device is engineered to provide a significant increase in cardiac output in patients with severe left ventricular impairment as well as in patients undergoing high-risk coronary intervention, and may provide substantive circulatory support when severe hemodynamic compromise occurs. It can potentially be maintained in situ for five to seven days. Canada's first implantations of an Impella device providing circulatory support in patients undergoing complex, high-risk PCI are reported. Larger studies will be required to identify whether a survival benefit or improvement in left ventricular function can be achieved when using the Impella device to support patients undergoing high-risk PCI or those in cardiogenic shock.
Jonas Eichhöfer; Mark Osten; Eric Horlick; Vladimír Dzavík
Related Documents :
15731546 - Mechanical ventricular assist system required for sustained severe cardiac dysfunction ...
17597046 - A novel mechanical circulatory approach for patients with cardiogenic shock in the inte...
708286 - Intra-aortic balloon pumping: theory and practice. experience with 325 patients.
18342746 - Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventr...
21239336 - Comparison of ionic and low-osmolar contrast media during cardiac catheterization.
16457936 - Hypotension, bradycardia and syncope caused by honey poisoning.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  24     ISSN:  1916-7075     ISO Abbreviation:  Can J Cardiol     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-06     Completed Date:  2008-12-10     Revised Date:  2010-09-23    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  e82-5     Citation Subset:  IM    
Division of Cardiology, University Health Network, University of Toronto, Ontario.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Combined Modality Therapy
Coronary Angiography
Critical Illness / therapy
Follow-Up Studies
Heart Catheterization / methods
Heart Failure / complications,  diagnosis,  therapy*
Heart Function Tests
Heart-Assist Devices*
Middle Aged
Myocardial Infarction / complications,  radiography,  therapy*
Risk Assessment
Stroke Volume
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Myocardial bridge: is the risk of perforation increased?
Next Document:  Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therap...